Pet Cancer Therapeutics Market Size, Share, Growth Report, 2034
Pet Cancer Therapeutics Market By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, and Radiation Therapy), By Species (Dogs, Cats, and Others), By Cancer Type (Lymphoma, Mast Cell Cancer, Melanoma, Mammary & Skin Cancer, and Others), By End-user (Veterinary Hospitals, Veterinary Clinics, and Research Institutes), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 213 Report Code: ZMR-4232
Published Date: May-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 4.78 Billion | USD 12.06 Billion | 9.7% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Pet Cancer Therapeutics Market, (2023 - 2030) (USD Million)
- 2.2 Global Pet Cancer Therapeutics Market : snapshot
- Chapter 3. Global Pet Cancer Therapeutics Market - Industry Analysis
- 3.1 Pet Cancer Therapeutics Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Rise in the occurrence of cancer in pets will proliferate the growth of the market across the globe
- 3.3 Market Restraints
- 3.3.1. Less availability of veterinary doctors can restrict the global industry expansion
- 3.4 Market Opportunities
- 3.4.1. Surge in the unmet medical requirements to open new growth avenues for the global market
- 3.5 Market Challenges
- 3.5.1. Government objection to use of high drug doses in treating pets suffering from cancer can prove a huge challenge for the global industry expansion
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Route of Administration
- 3.7.2 Market attractiveness analysis By Cancer Type
- 3.7.3 Market attractiveness analysis By Species Type
- Chapter 4. Global Pet Cancer Therapeutics Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Pet Cancer Therapeutics Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Pet Cancer Therapeutics Market - Route of Administration Analysis
- 5.1 Global Pet Cancer Therapeutics Market overview: By Route of Administration
- 5.1.1 Global Pet Cancer Therapeutics Market share, By Route of Administration, 2022 and 2030
- 5.2 Parenteral
- 5.2.1 Global Pet Cancer Therapeutics Market by Parenteral, 2023 - 2030 (USD Million)
- 5.3 Oral
- 5.3.1 Global Pet Cancer Therapeutics Market by Oral, 2023 - 2030 (USD Million)
- 5.4 Others
- 5.4.1 Global Pet Cancer Therapeutics Market by Others, 2023 - 2030 (USD Million)
- 5.1 Global Pet Cancer Therapeutics Market overview: By Route of Administration
- Chapter 6. Global Pet Cancer Therapeutics Market - Cancer Type Analysis
- 6.1 Global Pet Cancer Therapeutics Market overview: By Cancer Type
- 6.1.1 Global Pet Cancer Therapeutics Market share, By Cancer Type, 2022 and 2030
- 6.2 Melanoma
- 6.2.1 Global Pet Cancer Therapeutics Market by Melanoma, 2023 - 2030 (USD Million)
- 6.3 Lymphoma
- 6.3.1 Global Pet Cancer Therapeutics Market by Lymphoma, 2023 - 2030 (USD Million)
- 6.4 Mammary & squamous cell cancer
- 6.4.1 Global Pet Cancer Therapeutics Market by Mammary & squamous cell cancer, 2023 - 2030 (USD Million)
- 6.5 Mast cell cancer
- 6.5.1 Global Pet Cancer Therapeutics Market by Mast cell cancer, 2023 - 2030 (USD Million)
- 6.6 Others
- 6.6.1 Global Pet Cancer Therapeutics Market by Others, 2023 - 2030 (USD Million)
- 6.1 Global Pet Cancer Therapeutics Market overview: By Cancer Type
- Chapter 7. Global Pet Cancer Therapeutics Market - Species Type Analysis
- 7.1 Global Pet Cancer Therapeutics Market overview: By Species Type
- 7.1.1 Global Pet Cancer Therapeutics Market share, By Species Type, 2022 and 2030
- 7.2 Cat
- 7.2.1 Global Pet Cancer Therapeutics Market by Cat, 2023 - 2030 (USD Million)
- 7.3 Dog
- 7.3.1 Global Pet Cancer Therapeutics Market by Dog, 2023 - 2030 (USD Million)
- 7.4 Others
- 7.4.1 Global Pet Cancer Therapeutics Market by Others, 2023 - 2030 (USD Million)
- 7.1 Global Pet Cancer Therapeutics Market overview: By Species Type
- Chapter 8. Pet Cancer Therapeutics Market - Regional Analysis
- 8.1 Global Pet Cancer Therapeutics Market Regional Overview
- 8.2 Global Pet Cancer Therapeutics Market Share, by Region, 2022 & 2030 (USD Million)
- 8.3. North America
- 8.3.1 North America Pet Cancer Therapeutics Market, 2023 - 2030 (USD Million)
- 8.3.1.1 North America Pet Cancer Therapeutics Market, by Country, 2023 - 2030 (USD Million)
- 8.3.1 North America Pet Cancer Therapeutics Market, 2023 - 2030 (USD Million)
- 8.4 North America Pet Cancer Therapeutics Market, by Route of Administration, 2023 - 2030
- 8.4.1 North America Pet Cancer Therapeutics Market, by Route of Administration, 2023 - 2030 (USD Million)
- 8.5 North America Pet Cancer Therapeutics Market, by Cancer Type, 2023 - 2030
- 8.5.1 North America Pet Cancer Therapeutics Market, by Cancer Type, 2023 - 2030 (USD Million)
- 8.6 North America Pet Cancer Therapeutics Market, by Species Type, 2023 - 2030
- 8.6.1 North America Pet Cancer Therapeutics Market, by Species Type, 2023 - 2030 (USD Million)
- 8.4. Europe
- 8.4.2 Europe Pet Cancer Therapeutics Market, 2023 - 2030 (USD Million)
- 8.4.2.1 Europe Pet Cancer Therapeutics Market, by Country, 2023 - 2030 (USD Million)
- 8.4.2 Europe Pet Cancer Therapeutics Market, 2023 - 2030 (USD Million)
- 8.4 Europe Pet Cancer Therapeutics Market, by Route of Administration, 2023 - 2030
- 8.4.1 Europe Pet Cancer Therapeutics Market, by Route of Administration, 2023 - 2030 (USD Million)
- 8.5 Europe Pet Cancer Therapeutics Market, by Cancer Type, 2023 - 2030
- 8.5.1 Europe Pet Cancer Therapeutics Market, by Cancer Type, 2023 - 2030 (USD Million)
- 8.6 Europe Pet Cancer Therapeutics Market, by Species Type, 2023 - 2030
- 8.6.1 Europe Pet Cancer Therapeutics Market, by Species Type, 2023 - 2030 (USD Million)
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific Pet Cancer Therapeutics Market, 2023 - 2030 (USD Million)
- 8.5.3.1 Asia Pacific Pet Cancer Therapeutics Market, by Country, 2023 - 2030 (USD Million)
- 8.5.3 Asia Pacific Pet Cancer Therapeutics Market, 2023 - 2030 (USD Million)
- 8.4 Asia Pacific Pet Cancer Therapeutics Market, by Route of Administration, 2023 - 2030
- 8.4.1 Asia Pacific Pet Cancer Therapeutics Market, by Route of Administration, 2023 - 2030 (USD Million)
- 8.5 Asia Pacific Pet Cancer Therapeutics Market, by Cancer Type, 2023 - 2030
- 8.5.1 Asia Pacific Pet Cancer Therapeutics Market, by Cancer Type, 2023 - 2030 (USD Million)
- 8.6 Asia Pacific Pet Cancer Therapeutics Market, by Species Type, 2023 - 2030
- 8.6.1 Asia Pacific Pet Cancer Therapeutics Market, by Species Type, 2023 - 2030 (USD Million)
- 8.6. Latin America
- 8.6.4 Latin America Pet Cancer Therapeutics Market, 2023 - 2030 (USD Million)
- 8.6.4.1 Latin America Pet Cancer Therapeutics Market, by Country, 2023 - 2030 (USD Million)
- 8.6.4 Latin America Pet Cancer Therapeutics Market, 2023 - 2030 (USD Million)
- 8.4 Latin America Pet Cancer Therapeutics Market, by Route of Administration, 2023 - 2030
- 8.4.1 Latin America Pet Cancer Therapeutics Market, by Route of Administration, 2023 - 2030 (USD Million)
- 8.5 Latin America Pet Cancer Therapeutics Market, by Cancer Type, 2023 - 2030
- 8.5.1 Latin America Pet Cancer Therapeutics Market, by Cancer Type, 2023 - 2030 (USD Million)
- 8.6 Latin America Pet Cancer Therapeutics Market, by Species Type, 2023 - 2030
- 8.6.1 Latin America Pet Cancer Therapeutics Market, by Species Type, 2023 - 2030 (USD Million)
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa Pet Cancer Therapeutics Market, 2023 - 2030 (USD Million)
- 8.7.5.1 The Middle-East and Africa Pet Cancer Therapeutics Market, by Country, 2023 - 2030 (USD Million)
- 8.7.5 The Middle-East and Africa Pet Cancer Therapeutics Market, 2023 - 2030 (USD Million)
- 8.4 The Middle-East and Africa Pet Cancer Therapeutics Market, by Route of Administration, 2023 - 2030
- 8.4.1 The Middle-East and Africa Pet Cancer Therapeutics Market, by Route of Administration, 2023 - 2030 (USD Million)
- 8.5 The Middle-East and Africa Pet Cancer Therapeutics Market, by Cancer Type, 2023 - 2030
- 8.5.1 The Middle-East and Africa Pet Cancer Therapeutics Market, by Cancer Type, 2023 - 2030 (USD Million)
- 8.6 The Middle-East and Africa Pet Cancer Therapeutics Market, by Species Type, 2023 - 2030
- 8.6.1 The Middle-East and Africa Pet Cancer Therapeutics Market, by Species Type, 2023 - 2030 (USD Million)
- Chapter 9. Company Profiles
- 9.1 Karyopharm Therapeutics Inc.
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Zoetis
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Oasmia Pharmaceuticals AB
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Zenoaq
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 AB Science
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Aratana Therapeutics Inc.
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Rhizen Pharmaceuticals SA
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Morphogenesis Inc.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Boehringer Ingelheim International GmbH
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Regeneus Ltd.
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 VetDC Inc.
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 and others.
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.1 Karyopharm Therapeutics Inc.
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Pet Cancer Therapeutics Market, 2023 - 2030 (USD Million)
- 4. Porter’s Five Forces Analysis
- 5. Global Pet Cancer Therapeutics Market attractiveness, By Route of Administration
- 6. Global Pet Cancer Therapeutics Market attractiveness, By Cancer Type
- 7. Global Pet Cancer Therapeutics Market attractiveness, By Species Type
- 8. Global Pet Cancer Therapeutics Market share by Route of Administration, 2023 and 2030 (USD Million)
- 9. Global Pet Cancer Therapeutics Market by Parenteral, 2023 - 2030 (USD Million)
- 10. Global Pet Cancer Therapeutics Market by Oral, 2023 - 2030 (USD Million)
- 11. Global Pet Cancer Therapeutics Market by Others, 2023 - 2030 (USD Million)
- 12. Global Pet Cancer Therapeutics Market share by Cancer Type, 2023 and 2030 (USD Million)
- 13. Global Pet Cancer Therapeutics Market by Melanoma, 2023 - 2030 (USD Million)
- 14. Global Pet Cancer Therapeutics Market by Lymphoma, 2023 - 2030 (USD Million)
- 15. Global Pet Cancer Therapeutics Market by Mammary & squamous cell cancer, 2023 - 2030 (USD Million)
- 16. Global Pet Cancer Therapeutics Market by Mast cell cancer, 2023 - 2030 (USD Million)
- 17. Global Pet Cancer Therapeutics Market by Others, 2023 - 2030 (USD Million)
- 18. Global Pet Cancer Therapeutics Market share by Species Type, 2023 and 2030 (USD Million)
- 19. Global Pet Cancer Therapeutics Market by Cat, 2023 - 2030 (USD Million)
- 20. Global Pet Cancer Therapeutics Market by Dog, 2023 - 2030 (USD Million)
- 21. Global Pet Cancer Therapeutics Market by Others, 2023 - 2030 (USD Million)
- 22. Global Pet Cancer Therapeutics Market share, by Region, 2023 and 2030
- 23. North America Pet Cancer Therapeutics Market, 2023 - 2030 (USD Million)
- 24. Europe Pet Cancer Therapeutics Market, 2023 - 2030 (USD Million)
- 25. Asia Pacific Pet Cancer Therapeutics Market, 2023 - 2030 (USD Million)
- 26. Latin America Pet Cancer Therapeutics Market, 2023 - 2030 (USD Million)
- 27. The Middle-East and Africa Pet Cancer Therapeutics Market, 2023 - 2030 (USD Million)
Table Of Tables
- 1. Global Pet Cancer Therapeutics Market: Snapshot
- 2. Drivers of the Pet Cancer Therapeutics Market: impact analysis
- 3. North America Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 4. North America Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 5. North America Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 6. U.S. Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 7. U.S. Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 8. U.S. Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 9. Canada Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 10. Canada Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 11. Canada Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 12. Europe Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 13. Europe Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 14. Europe Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 15. Germany Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 16. Germany Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 17. Germany Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 18. France Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 19. France Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 20. France Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 21. U.K. Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 22. U.K. Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 23. U.K. Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 24. Italy Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 25. Italy Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 26. Italy Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 27. Spain Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 28. Spain Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 29. Spain Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 30. Rest of Europe Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 31. Rest of Europe Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 32. Rest of Europe Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 33. Asia Pacific Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 34. Asia Pacific Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 35. Asia Pacific Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 36. China Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 37. China Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 38. China Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 39. Japan Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 40. Japan Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 41. Japan Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 42. India Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 43. India Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 44. India Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 45. South Korea Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 46. South Korea Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 47. South Korea Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 48. South-East Asia Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 49. South-East Asia Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 50. South-East Asia Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 51. Rest of Asia Pacific Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 52. Rest of Asia Pacific Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 53. Rest of Asia Pacific Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 54. Latin America Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 55. Latin America Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 56. Latin America Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 57. Brazil Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 58. Brazil Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 59. Brazil Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 60. Mexico Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 61. Mexico Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 62. Mexico Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 63. Rest of Latin America Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 64. Rest of Latin America Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 65. Rest of Latin America Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 66. The Middle-East and Africa Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 67. The Middle-East and Africa Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 68. The Middle-East and Africa Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 69. GCC Countries Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 70. GCC Countries Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 71. GCC Countries Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 72. South Africa Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 73. South Africa Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 74. South Africa Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
- 75. Rest of Middle-East Africa Pet Cancer Therapeutics Market revenue, By Route of Administration, 2023 - 2030 (USD Million)
- 76. Rest of Middle-East Africa Pet Cancer Therapeutics Market revenue, By Cancer Type, 2023 - 2030 (USD Million)
- 77. Rest of Middle-East Africa Pet Cancer Therapeutics Market revenue, By Species Type, 2023 - 2030 (USD Million)
Methodology
FrequentlyAsked Questions
Pet cancer therapeutics is a new anti-cancer medicine having the capacity to reduce the negative impact of cancer tissues.
The global pet cancer therapeutics market is expected to grow due to increasing pet ownership, rising awareness of veterinary oncology, and advancements in targeted therapies and diagnostics.
According to a study, the global pet cancer therapeutics market size was worth around USD 4.78 billion in 2024 and is expected to reach USD 12.06 billion by 2034.
The global pet cancer therapeutics market is expected to grow at a CAGR of 9.7% during the forecast period.
North America is expected to dominate the pet cancer therapeutics market over the forecast period.
Leading players in the global pet cancer therapeutics market include Karyopharm Therapeutics Inc., Zoetis, Oasmia Pharmaceuticals AB, Zenoaq, AB Science, Aratana Therapeutics Inc., Rhizen Pharmaceuticals SA, Morphogenesis Inc., Boehringer Ingelheim International GmbH, Regeneus Ltd., and VetDC Inc., among others.
The report explores crucial aspects of the pet cancer therapeutics market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients
